First Mercantile Trust’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$522K Sell
623
-14
-2% -$14.2K 0.07% 178
2021
Q2
$809K Buy
637
+258
+68% +$291K 0.1% 120
2021
Q1
$416K Sell
379
-81
-18% -$107K 0.05% 217
2020
Q4
$656K Sell
460
-184
-29% -$196K 0.07% 148
2020
Q3
$651K Sell
644
-23
-3% -$16.7K 0.08% 142
2020
Q2
$467K Buy
667
+221
+50% +$128K 0.06% 184
2020
Q1
$156K Sell
446
-684
-61% -$484K 0.02% 426
2019
Q4
$711K Sell
1,130
-243
-18% -$119K 0.08% 151
2019
Q3
$460K Buy
1,373
+273
+25% +$87.5K 0.05% 259
2019
Q2
$286K Sell
1,100
-136
-11% -$27.2K 0.03% 327
2019
Q1
$205K Sell
1,236
-53
-4% -$8.62K 0.05% 447
2018
Q4
$140K Buy
1,289
+689
+115% +$116K 0.03% 542
2018
Q3
$150K Buy
600
+234
+64% +$50.3K 0.03% 594
2018
Q2
$80K Buy
366
+341
+1,364% +$63.1K 0.02% 756
2018
Q1
$4K Buy
+25
New +$4.23K ﹤0.01% 757

Other funds holding CDLX

First Mercantile Trust's CDLX Position: Q3 2021 in Review

First Mercantile Trust reduced its Cardlytics (CDLX) stake by 2.2% in Q3 2021, selling an estimated $14.2K and leaving 623 shares worth $522K. The position accounts for 0.07% of the portfolio, ranked #178.

First Mercantile Trust first reported a position in CDLX in Q1 2018 and has held it in 15 quarters since. The position peaked at $809K in Q2 2021. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

  • First Mercantile Trust held 623 shares of Cardlytics worth $522K as of Q3 2021.
  • First Mercantile Trust sold 14 Cardlytics shares in Q3 2021, an estimated $14.2K.
  • Cardlytics made up 0.07% of First Mercantile Trust's portfolio in Q3 2021, its #178 holding.
  • First Mercantile Trust first reported a position in Cardlytics in Q1 2018 and has held it in 15 quarters since.
  • First Mercantile Trust's Cardlytics position peaked at $809K in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.